A Prospective Trial Comparing The Response To Hyperbaric Oxygen Treatment In Patients With Ulcerative And Non-Ulcerative Interstitial Cystitis

Approval Date: 1/20/2011

Principal Investigator: Kenneth Peters, MD and David Wenzler, MD

This 18-month study will evaluate the use of hyperbaric oxygen in patients with interstitial cystitis.

Hyperbaric oxygen therapy uses 100 percent oxygen at increased pressure to stimulate healing. Breathing oxygen at higher pressures will increase the body's ability to carry oxygen-rich blood to tissues. This improves the ability to heal by growing new blood vessels. In order to achieve this benefit, treatment must be given inside a pressurized chamber.

The study will consist of an enrollment visit at the clinic, then 30 consecutive (Monday through Friday) visits during a six-week course of hyperbaric oxygen treatments at the Beaumont Health Center. During the treatment phase of the study, patients will be required to come to the clinic three times. The patients would then have three additional clinic visits after treatments are complete - at 3, 6 and 12 months.

Eligibility:

Please contact Urology Research for eligibility requirements.

Contact Person:
Urology Research
248-551-3565

Status of Clinical Trial:
open and enrolling